Skip to Content

Cipla 125 (Topiramate 200 mg)

Pill with imprint Cipla 125 is Pink, Capsule-shape and has been identified as Topiramate 200 mg. It is supplied by Cipla USA Inc..

Topiramate is used in the treatment of migraine prevention; bipolar disorder; seizures; seizure prevention; borderline personality disorder (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Cipla 125

Topiramate

Imprint:
Cipla 125
Strength:
200 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cipla USA Inc.
National Drug Code (NDC):
69097-0125

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide